← Back to Search

Philadelphia ACE Survey for Coronary Artery Disease

N/A

Recruiting

Led By Robert Maunder, MD

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 and 6 months

Awards & highlights

Study Summary

This trial will test whether ACE screening improves quality of life for patients with CAD.

Eligible Conditions

Coronary Artery Disease
Adverse Childhood Experiences

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient-reported quality of life

Secondary outcome measures

Cardiovascular hospitalization

Mortality

Myocardial infarction

+2 more

Other outcome measures

Angina Pectoris

Anxiety

Depression

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Lifestyle AssessmentExperimental Treatment1 Intervention

At the initial visit, no Philadelphia ACE Survey will be administered. The Lifestyle Assessment packaged will be provided for self-completion, featuring General Demographics, Cardiovascular and Medication History, Health Behaviours, the Short Form (36) Health Survey, the Patient Health Questionnaire-9, the General Anxiety Disorder-7 questionnaire, the Seattle Angina Questionnaire-7, and the modified Perceived Need for Card Questionnaire. At 3 months, the Lifestyle Assessment will be administered again. At 6 months, the Philadelphia ACE survey, Lifestyle Assessment, as well as a scale assessing their comfort level in being screened for ACE, disclosing their ACE status to their clinicians, and their confidence level in their clinicians' ability to help them manage their ACEs will be administered.

Group II: ACE ScreenExperimental Treatment2 Interventions

At the initial visit, the Philadelphia ACE Survey, a validated ACE questionnaire, will be administered by a research coordinator. A Lifestyle Assessment package will also be provided for self-completion, featuring General Demographics, Cardiovascular and Medication History, Health Behaviours, the Short Form (36) Health Survey, the Patient Health Questionnaire-9, the General Anxiety Disorder-7 questionnaire, the Seattle Angina Questionnaire-7, and the modified Perceived Need for Card Questionnaire. Patients who test positive for ACE will receive a 3-page printed ACE Resource Pack. At 3 months, the Lifestyle Assessment will be administered again. At 6 months, the Philadelphia ACE survey, Lifestyle Assessment, as well as a scale assessing their comfort level in being screened for ACE, disclosing their ACE status to their clinicians, and their confidence level in their clinicians' ability to help them manage their ACEs will be administered.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Socar Research SANETWORK

2 Previous Clinical Trials

89 Total Patients Enrolled

University Health Network, TorontoLead Sponsor

1,468 Previous Clinical Trials

484,390 Total Patients Enrolled

12 Trials studying Coronary Artery Disease

7,983 Patients Enrolled for Coronary Artery Disease

Robert Maunder, MDPrincipal InvestigatorMount Sinai Hospital, Canada

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are participating in the experiment?

"Affirmative. According to the clinicaltrials.gov listing, this trial is still recruiting subjects and was initially advertised on September 1st 2021 with a subsequent update dated May 27th 2022. The medical study requires 100 participants from one location."

Answered by AI

Has registration for this trial commenced?

"True, the information on clinicaltrials.gov suggests that this experiment is still searching for participants. The trial began enrollment on September 1st 2021 and was recently updated on May 27th 2022; they are hoping to find 100 people from a single location."

Answered by AI

Recent research and studies

JAMA CardiologyJournal

Association of Adverse Childhood Experiences with Cardiovascular Disease Later in Life

Godoy, Lucas C., Claudia Frankfurter, Matthew Cooper, Christine Lay, Robert Maunder, and Michael E. Farkouh. 2021. “Association of Adverse Childhood Experiences with Cardiovascular Disease Later in Life”. JAMA Cardiology. American Medical Association (AMA). doi:10.1001/jamacardio.2020.6050.

BMC Health Services ResearchJournal

Physicians’ Knowledge and Practices Regarding Screening Adult Patients for Adverse Childhood Experiences: A Survey

Maunder, Robert G., Jonathan J. Hunter, David W. Tannenbaum, Thao Lan Le, and Christine Lay. 2020. “Physicians’ Knowledge and Practices Regarding Screening Adult Patients for Adverse Childhood Experiences: A Survey”. BMC Health Services Research. Springer Science and Business Media LLC. doi:10.1186/s12913-020-05124-6.

American Journal of Preventive MedicineJournal

Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults

Felitti, Vincent J, MD, FACP, Robert F Anda MD, MS, Dale Nordenberg MD, David F Williamson MS, PhD, Alison M Spitz MS, MPH, Valerie Edwards BA, Mary P Koss PhD, and James S Marks MD, MPH. 1998. “Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults”. American Journal of Preventive Medicine. Elsevier BV. doi:10.1016/s0749-3797(98)00017-8.

BMC Cardiovascular DisordersJournal